Table 1.

Demographic and clinical data of all patients.

Patient cohort	All	Subgroup I (Stand-alone PET)	Subgroup II (Hybrid PET/MR)
Patients	84	56	28
Gender, f/m	34/50	24/32	10/18
Mean age ± SD	54 ± 14 y	55 ± 13 y	50 ± 16 y
Age range	22–76 y	23–76 y	22–76 y
IDH genotype, wt/mut	58/26	41/15	17/11
WHO grade II (wt/mut)	7 (1/6)	5 (0/5)	2 (1/1)
WHO grade III (wt/mut)	26 (11/15)	17 (10/7)	9 (1/8)
WHO grade IV (wt/mut)	51 (46/5)	34 (31/3)	17 (15/2)